OppenheimerFunds’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-650,190
| Closed | -$14.8M | – | 1756 |
|
|
2016
Q2 | $14.8M | Sell |
650,190
-450,655
| -41% | -$10.2M | 0.02% | 644 |
|
|
2016
Q1 | $20.7M | Sell |
1,100,845
-2,640
| -0.2% | -$49.6K | 0.03% | 553 |
|
|
2015
Q4 | $18.1M | Buy |
1,103,485
+12,120
| +1% | +$199K | 0.02% | 606 |
|
|
2015
Q3 | $12M | Sell |
1,091,365
-5,540
| -0.5% | -$60.9K | 0.02% | 683 |
|
|
2015
Q2 | $14.3M | Buy |
1,096,905
+7,500
| +0.7% | +$97.7K | 0.02% | 674 |
|
|
2015
Q1 | $18.9M | Buy |
1,089,405
+3,230
| +0.3% | +$56K | 0.02% | 610 |
|
|
2014
Q4 | $16.2M | Buy |
1,086,175
+430
| +0% | +$6.42K | 0.02% | 637 |
|
|
2014
Q3 | $25M | Buy |
1,085,745
+126
| +0% | +$2.9K | 0.03% | 513 |
|
|
2014
Q2 | $34.6M | Buy |
+1,085,619
| New | +$34.6M | 0.04% | 439 |
|